REG - Coca-Cola EP PLC - Transactions in Own Shares

Coca-Cola Europacific PartnersAnnouncement

22/04/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250422:nRSV6372Fa&default-theme=true

RNS Number : 6372F  Coca-Cola Europacific Partners plc  22 April 2025

Coca-Cola Europacific Partners plc (the "Company")

Transactions in Own Shares

 

The Company confirms that on:

(a)  17 April 2025 it purchased a total of: (i) 39,051 ordinary shares of EUR
0.01 ("ordinary shares") on the US Trading Venues(( 1 )) and (ii) 18,767
ordinary shares on the London Trading Venues(( 2 ));  and

(b)  21 April 2025 it purchased a total of: (i) 39,314 ordinary shares of EUR
0.01 on the US Trading Venues and (ii) 0 ordinary shares(3) on the London
Trading Venues,

in each case, from Goldman Sachs & Co. LLC, Goldman Sachs International or
one of their affiliates, as detailed below.

The repurchased ordinary shares will be cancelled.

17 April 2025

                                                          US Trading Venues  London Stock Exchange  CBOE Europe Limited  CBOE Europe Limited  Aquis

                                                                                                    (CXE)                (BXE)

 Date of purchase                                         17 April           17 April               17 April             17 April             17 April

                                                          2025               2025                   2025                 2025                 2025
 Aggregate number of ordinary shares purchased            39,051             11,373                 1,887                5,507                0
 Highest price paid (per ordinary share)                  USD 89.7300        GBP 67.6000            GBP 67.5000          GBP 67.6000          GBP 0
 Lowest price paid (per ordinary share)                   USD 88.0400        GBP 66.5000            GBP 66.6000          GBP 66.5000          GBP 0
 Volume weighted average price paid (per ordinary share)  USD 89.2213        GBP 67.0989            GBP 67.0980          GBP 67.0455          GBP 0

 

 

 

21 April 2025

 

                                                          US Trading Venues  London Stock Exchange  CBOE Europe Limited  CBOE Europe Limited  Aquis

                                                                                                    (CXE)                (BXE)

 Date of purchase                                         21 April           21 April               21 April             21 April             21 April

                                                          2025               2025                   2025                 2025                 2025
 Aggregate number of ordinary shares purchased            39,314             0                      0                    0                    0
 Highest price paid (per ordinary share)                  USD 89.3700        GBP 0                  GBP 0                GBP 0                GBP 0
 Lowest price paid (per ordinary share)                   USD 87.5600        GBP 0                  GBP 0                GBP 0                GBP 0
 Volume weighted average price paid (per ordinary share)  USD 88.6265        GBP 0                  GBP 0                GBP 0                GBP 0

 

 

The purchases form part of the Company's share buyback programme announced on
14 February 2025 (the "Programme"). In connection with the Programme, the
Company expects to repurchase up to EUR 1 billion of ordinary shares (in
aggregate).

This announcement does not constitute, or form part of, an offer or
solicitation of an offer for securities in any jurisdiction.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it
applies in the UK (the Market Abuse Regulation), full details of the
transactions, are set out in the Schedule to this announcement available
through the link below:

http://www.rns-pdf.londonstockexchange.com/rns/6372F_1-2025-4-21.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/6372F_1-2025-4-21.pdf)

 

CONTACTS

 Company Secretariat                                    Investor Relations                                       Media Relations

 Clare Wardle                                           Sarah Willett                                            Shanna Wendt

 clare.wardle@ccep.com (mailto:clare.wardle@ccep.com)   sarah.willett@ccep.com (mailto:sarah.willett@ccep.com)   mediaenquiries@ccep.com (mailto:mediaenquiries@ccep.com)

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods
companies. We make, move and sell some of the world's most loved brands -
serving nearly 600 million consumers and helping over 4 million customers
across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an
expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock
Exchange and on the Spanish Stock Exchanges, and a constituent of both the
Nasdaq 100 and FTSE 100 indices, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com
(http://www.cocacolaep.com/) and follow CCEP on LinkedIn
(https://www.linkedin.com/company/coca-cola-europacific-partners/)

 

 

 

 

 

 1  The "US Trading Venues" comprise Nasdaq and other applicable US trading
venues.

 2  The "London Trading Venues" comprise the London Stock Exchange, CBOE
Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis. Goldman Sachs
acquired CREST Depositary Interests on the London Trading Venues, which will
be cancelled together with the underlying shares they represent.

3 No ordinary shares were purchased on the London Trading Venues on 21 April
2025 due to market closure for the UK's Easter Monday Bank Holiday.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSPKDBDBBKBOQB